Literature DB >> 9234241

Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes.

T M Fu1, J B Ulmer, M J Caulfield, R R Deck, A Friedman, S Wang, X Liu, J J Donnelly, M A Liu.   

Abstract

BACKGROUND: MHC class I molecule-restricted cytotoxic T-lymphocyte (CTL) responses are induced following either intramuscular (i.m.) injection of a DNA plasmid encoding influenza virus nucleoprotein (NP) or transplantation of myoblasts stably transfected with the NP gene, the latter indicating that synthesis of NP by myocytes in vivo is sufficient to induce CTL. The present study was designed to investigate the role of muscle cells and involvement of professional antigen-presenting cells (APCs) in priming CTL responses following DNA vaccination.
MATERIALS AND METHODS: Parent-->F1 bone marrow (BM) chimeric mice were generated whose somatic cells include muscle cells bearing both parental MHC haplotypes, while their professional APCs express only the donor MHC haplotypes. RESULTS AND
CONCLUSIONS: Upon injection of NP DNA, or after infection with influenza virus, CTL responses generated in the chimeras were restricted to the donor MHC haplotype. Thus cells of BM lineage were definitively shown to be responsible for priming such CTL responses after infection or DNA immunization. Moreover, expression of antigen by muscle cells in BM chimeric mice after myoblast transplantation is sufficient to induce CTL restricted only by the MHC haplotype of the donor BM. This indicates that transfer of antigen from myocytes to professional APCs can occur, thus obviating a requirement for direct transfection of BM-derived cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9234241      PMCID: PMC2230213     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  26 in total

Review 1.  Peptides naturally presented by MHC class I molecules.

Authors:  H G Rammensee; K Falk; O Rötzschke
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

Review 2.  MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation.

Authors:  R N Germain
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

3.  Direct gene transfer into mouse muscle in vivo.

Authors:  J A Wolff; R W Malone; P Williams; W Chong; G Acsadi; A Jani; P L Felgner
Journal:  Science       Date:  1990-03-23       Impact factor: 47.728

4.  Human myoblasts as antigen-presenting cells.

Authors:  N Goebels; D Michaelis; H Wekerle; R Hohlfeld
Journal:  J Immunol       Date:  1992-07-15       Impact factor: 5.422

5.  Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors.

Authors:  D L Montgomery; J W Shiver; K R Leander; H C Perry; A Friedman; D Martinez; J B Ulmer; J J Donnelly; M A Liu
Journal:  DNA Cell Biol       Date:  1993-11       Impact factor: 3.311

6.  Heterologous protection against influenza by injection of DNA encoding a viral protein.

Authors:  J B Ulmer; J J Donnelly; S E Parker; G H Rhodes; P L Felgner; V J Dwarki; S H Gromkowski; R R Deck; C M DeWitt; A Friedman
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

7.  Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens.

Authors:  A Y Huang; P Golumbek; M Ahmadzadeh; E Jaffee; D Pardoll; H Levitsky
Journal:  Science       Date:  1994-05-13       Impact factor: 47.728

8.  Effector cell expression of NK1.1, a murine natural killer cell-specific molecule, and ability of mice to reject bone marrow allografts.

Authors:  C L Sentman; V Kumar; G Koo; M Bennett
Journal:  J Immunol       Date:  1989-03-15       Impact factor: 5.422

9.  Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cells.

Authors:  S Nair; J S Babu; R G Dunham; P Kanda; R L Burke; B T Rouse
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

10.  Systemic delivery of recombinant proteins by genetically modified myoblasts.

Authors:  E Barr; J M Leiden
Journal:  Science       Date:  1991-12-06       Impact factor: 47.728

View more
  72 in total

1.  Induction of antiviral antibodies by DNA immunization requires neither perforin-mediated nor CD8(+)-T-cell-mediated lysis of antigen-expressing cells.

Authors:  D E Hassett; J Zhang; J L Whitton
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies.

Authors:  K Nagaraju; N Raben; L Loeffler; T Parker; P J Rochon; E Lee; C Danning; R Wada; C Thompson; G Bahtiyar; J Craft; R Hooft Van Huijsduijnen; P Plotz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

3.  C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis.

Authors:  S Youssef; G Maor; G Wildbaum; N Grabie; A Gour-Lavie; N Karin
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

4.  Infection of human dendritic cells by a sindbis virus replicon vector is determined by a single amino acid substitution in the E2 glycoprotein.

Authors:  J P Gardner; I Frolov; S Perri; Y Ji; M L MacKichan; J zur Megede; M Chen; B A Belli; D A Driver; S Sherrill; C E Greer; G R Otten; S W Barnett; M A Liu; T W Dubensky; J M Polo
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Partial reconstitution of the CD4+-T-cell compartment in CD4 gene knockout mice restores responses to tuberculosis DNA vaccines.

Authors:  Sushila D'Souza; Marta Romano; Johanna Korf; Xiao-Ming Wang; Pierre-Yves Adnet; Kris Huygen
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

Review 6.  Poly-N-acetyl glucosamine gel matrix as a non-viral delivery vector for DNA-based vaccination.

Authors:  Mohamed L Salem; Marina Demcheva; William E Gillanders; David J Cole; John N Vournakis
Journal:  Anticancer Res       Date:  2010-10       Impact factor: 2.480

7.  Systemic protein delivery by muscle-gene transfer is limited by a local immune response.

Authors:  Lixin Wang; Eric Dobrzynski; Alexander Schlachterman; Ou Cao; Roland W Herzog
Journal:  Blood       Date:  2005-02-15       Impact factor: 22.113

8.  Targeting hepatitis B virus antigens to dendritic cells by heat shock protein to improve DNA vaccine potency.

Authors:  Qin-Long Gu; Xue Huang; Wen-Hong Ren; Lei Shen; Bing-Ya Liu; Si-Yi Chen
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

Review 9.  DNA vaccines against human immunodeficiency virus type 1 in the past decade.

Authors:  Malavika Giri; Kenneth E Ugen; David B Weiner
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

10.  Combined administration with DNA encoding vesicular stomatitis virus G protein enhances DNA vaccine potency.

Authors:  Chih-Ping Mao; Chien-Fu Hung; Tae Heung Kang; Liangmei He; Ya-Chea Tsai; Chao-Yi Wu; T-C Wu
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.